New sedative may cut breathing risks during IVF procedure

NCT ID NCT07335536

Recruiting now Symptom relief Sponsor: Diansan Su Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a sedative called remimazolam, combined with alfentanil, can lower the chance of low oxygen levels (hypoxia) during egg retrieval for IVF. About 400 women aged 18-50 will be randomly assigned to receive either remimazolam or the standard drug propofol. The goal is to see which combination is safer and reduces breathing complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPOXIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hypoxia infertility disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPOXIA INFERTILITY INFERTILITY ASSISTED REPRODUCTIVE TECHNOLOGY

Contacts and locations

Locations

Dongyang People's Hospital
NOT_YET_RECRUITING

Dongyang, Zhejiang, 322100, China
Lishui People's Hospital
NOT_YET_RECRUITING

Lishui, Zhejiang, 323000, China
The First Affiliated Hospital, Zhejiang University School of Medicine
RECRUITING

Hangzhou, Zhejiang, 310000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.